Equity
Equity Analysis
Price
 Gainers & Losers
 Weekly Gainers & Losers
 Monthly Gainers & Losers
 Out & Under Performers
 Advances & Declines
 New Highs & Lows
 52 Week Highs & Lows
 Weightage
 Only Buyers & Sellers
 Historical Returns
Volume
Analysis
Exchange Holidays
News Analysis
Corporate Action
Corporate Info
Other Market
  Home   >  CORPORATE ACTION  > Board Meetings
Board   Meetings      
As On Mar 24,2026
Options:
Aptus Pharma  
Bonus issue & Increase in Authorised Capital Inter alia, to consider ........
Ashapura Minechem  
Employees Stock Option Plan
DAR Credit & Capital  
Fund Raising
Dev Accelerator  
Preferential Issue of shares & Issue Of Warrants Inter alia, to con ........
Diamines & Chemicals  
Inter alia, to transact following business conversion of warrants i ........
DRA Consultants  
Inter alia, to consider and approve:- 1. Review of Business Operat ........
Eleganz Interiors  
Fund Raising/Other business matters
Guj. Cotex  
Rights Issue
India Homes  
Inter alia, to consider and approve conversion of outstanding loans ........
Jonjua Overseas  
Inter alia, to consider the following matters: 1. To consider and ........
Marvel Decor  
Fund Raising/Other business matters
Midland Polymers  
Inter alia, to consider and transact the following business:- 1. T ........
Natco Pharma  
Scheme of Arrangement Inter alia, to consider among other things, t ........
Purple Finance  
Inter alia, to consider and approve the proposal for fund raising b ........
Rose Merc  
Inter alia, to consider and approve:- 1. The Allotment of Equity ........
Salem Erode Invest  
Right Issue of Equity Shares
Sasken Technologies  
Inter alia, to consider business related matters. ........
Solara Active Pharma  
Inter alia, to consider and approve :- a) To consider making Secon ........
TVS Motor  
Interim Dividend
Viji Finance  
Issue Of Warrants Inter alia, to transact the following businesses: ........
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.